MedPath

Online COgnitive Behavioural Therapy for Sleep and Mental Health for Older Adults With Insomnia and Subjective Cognitive Complaints

Not Applicable
Recruiting
Conditions
Insomnia
Interventions
Behavioral: cognitive behavioral therapy for sleep, anxiety, and depression
Behavioral: education about healthy nutrition habits and communication in older age
Registration Number
NCT06032377
Lead Sponsor
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Brief Summary

The goal of this randomized controlled clinical trial is to assess a novel cognitive-behavioral program for sleep and mental health using a multidomain web platform (eCBTi+) in participants with insomnia and subjective cognitive complaint. The main questions it aims to answer are:

* Whether the eCBTi+ intervention improves sleep (subjective: Insomnia severity index \[ISI\], objective: EEG-based sleep efficiency) sleep and mental health (Geriatric Anxiety Index \[GAI\] and Geriatric Depression Scale \[GDS\]) compared to the control intervention

* Whether the eCBTi+ intervention improves cognitive abilities (subjective: Cognitive Failure Questionnaire \[CFQ\], objective: CANTAB executive functions composite score) compared to the control intervention

Detailed Description

Participants with insomnia disorder will complete:

* A phone interview

* Two video conferences (assessment of eligibility and tutorial to set up sleep monitoring devices)

* 9 nights of at-home polysomnography with an EEG headband (3 times x 3 nights)

* 42 sleep diaries (3 times x 14 days)

* 42 days wearing an actigraphy device (3 times x 14 days)

* Online questionnaires

* Phone call for a check-in with a psychologist

* 3 cognitive testing sessions

* 10 modules of online information on health, over the course of 10 weeks

* In MRI subgroup: 2 in-person testing

Good sleeper participants will complete:

* A phone interview

* Two video conferences (assessment of eligibility and tutorial to set up sleep monitoring devices)

* 3 nights of at-home polysomnography with an EEG headband

* 14 sleep diaries

* 14 days wearing an actigraphy device

* Online questionnaires

* 1 cognitive testing session

* 1 in person session for MRI.

In addition, researchers will compare outcomes from participants with insomnia and subjective cognitive complaint to a group of good sleepers to have normative values for imaging data.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
275
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
online cognitive behavioral therapy for insomnia, anxiety and depressioncognitive behavioral therapy for sleep, anxiety, and depression10 self-directed modules of cognitive behavioral therapy for insomnia, anxiety and depression, delivered online, once a week
online intervention on nutrition and communication in older ageeducation about healthy nutrition habits and communication in older age10 self-directed modules on healthy nutrition habits and communication strategies, delivered online, once a week
Primary Outcome Measures
NameTimeMethod
Geriatric depression scaleAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Geriatric depression scale. GDS scores range from 0 to 15, higher scores mean more severe depression symptoms.

Objective cognitive performance based on a composite score for executive functions from the CANTABAt baseline and at 24 weeks after the start of the intervention

Change in the Cambridge Neuropsychological Test Automated Battery (CANTAB) executive functions composite score (Intra-Extra Dimensional Set Shift \[IED\] and Stocking of Cambridge \[SOC\], ranging from 0 to 100 with higher scores reflecting poorer executive functions.

Insomnia severity indexAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Insomnia Severity Index. ISI range from 0 to 28, higher score means more severe insomnia symptoms.

Subjective cognitive impairment based on cognitive failure questionnaireAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Cognitive Failure Questionnaire (CFQ) total score as well as number of items with a score ≥ 3. The CFQ comprises 25 items and total score corresponds to the sum of all completed items, total score range from 0 to 100.

Geriatric anxiety indexAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Geriatric anxiety index. GAI scores range from 0 to 20 and higher scores mean more severe anxiety symptoms.

Secondary Outcome Measures
NameTimeMethod
Objective sleep measures based on actigraphy: Sleep LatencyAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Sleep Latency (SL) from actigraphs. Sleep latency in minutes, greater values mean longer time to fall asleep.

Objective sleep measures based on actigraphy: Total Sleep TimeAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Total Sleep Time (TST) from actigraphs. Total Sleep Time in minutes, greater values mean longer time spent asleep.

Sleep quality based on the Pittsburgh sleep quality indexAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Pittsburgh sleep quality index. PSQI scores range from 0 to 21, higher scores mean worse sleep quality.

Objective sleep measures based on actigraphy: Sleep EfficiencyAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Sleep Efficiency (SE) from actigraphs. Sleep efficiency ranges from 0 to 100, values closer to 100 mean greater sleep efficiency.

Subjective sleep measures based on sleep diaries: Wake After Sleep OnsetAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Wake After Sleep Onset (WASO) from sleep diaries. Wake After Sleep Onset in minutes, greater values mean longer time spent awake.

Cognitive performances from the CANTAB: Intra-Extra Dimensional Set Shift (IED)At baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Intra-Extra Dimensional Set Shift, IED - number of times that the subject failed to select the stimulus compatible with the current rule on the stage where the extra-dimensional shift occurs (range: 0-50; good to bad); Total errors adjusted (range: 0-402; good to bad)

Fractional anisotropyAt baseline, at 24 weeks after the start of the intervention

Change in fractional anisotropy of the superior longitudinal fasciculus and internal capsule.

Objective sleep measures based on actigraphy: Wake After Sleep OnsetAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Wake After Sleep Onset (WASO) from actigraphs. Wake After Sleep Onset in minutes, greater values mean longer time spent awake.

Cognitive performances from the CANTAB: Spatial Working Memory (SWM)At baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Spatial Working Memory \[SWM - Number of times the subject incorrectly revisits a box in which a token has previously been found (range: 0 - ∞; good to bad)\].

Objective sleep measures based on EEG: Sleep EfficiencyAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Sleep Efficiency (SE) from EEG. Sleep efficiency ranges from 0 to 100, values closer to 100 mean greater sleep efficiency.

Subjective sleep measures based on sleep diaries: Sleep EfficiencyAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Sleep Efficiency (SE) from sleep diaries. Sleep efficiency ranges from 0 to 100, values closer to 100 mean greater sleep efficiency.

Subjective sleep measures based on sleep diaries: Total Sleep TimeAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Total Sleep Time (TST) from sleep diaries. Total Sleep Time in minutes, greater values mean longer time spent asleep.

Cognitive performances from the CANTAB: Rapid Visual Information Processing (RVP)At baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Rapid Visual Information Processing RVP - A' (sensitivity to the target sequence) and probability of false alarm (range: 0.00 - 1.00; bad to good)\].

Cognitive performances from the CANTAB: Stocking of Cambridge (SOC)At baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Stocking of Cambridge, SOC - Number of problems successfully completed in the minimum possible number of moves (range: 0 - 12; bad to good); Mean number of moves required to complete problems (range: 5 - 12; good to bad); Initial thinking time median (range: 0 ms to ∞; longer times may indicate better planning efforts

Adherence to treatmentAt 10-12 weeks after the start of the intervention

Number of modules completed as a measure of treatment adherence

Objective sleep measures based on EEG: Slow Wave SleepAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Slow Wave Sleep (SWS) from EEG. Slow Wave Sleep in minutes, greater values mean longer time spent in Slow Wave Sleep.

Subjective sleep measures based on sleep diaries: Sleep LatencyAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Sleep Latency (SL) from sleep diaries. Sleep latency in minutes, greater values mean longer time to fall asleep.

Cognitive performances from the CANTAB: Spatial Span (SSP)At baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Spatial Span \[SSP - Forward/Reverse Span Lengths (range: 2-9; bad to good\]

Cognitive performances from the CANTAB: Paired Associates Learning (PAL)At baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Paired Associates Learning \[PAL - Total errors adjusted (range: 0 - 70; good to bad; First attempt memory score (range: 0-20; bad to good)\]

Negative emotional bias measured on the Cambridge Neuropsychological Test Automated Battery (CANTAB)At baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Emotional Bias Task (EBT) subscales from the CANTAB \[EBT - proportion of trials rated as 'Happy' (range: 0-15, bad to good)\].

Resting-state measuresAt baseline, at 24 weeks after the start of the intervention

Change in the ratio between segregation and integration within and between the default-mode network and the limbic network during resting-state as measured with functional connectivity.

GABA/glutamate ratio from magnetic resonance spectroscopyAt baseline, at 24 weeks after the start of the intervention

Change in the GABA/glutamate ratio in the anterior cingulate cortex.

Objective sleep measures based on EEG: Sleep LatencyAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Sleep Latency (SL) from EEG. Sleep latency in minutes, greater values mean longer time to fall asleep

Objective sleep measures based on EEG: Total Sleep TimeAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Total Sleep Time (TST) from EEG. Total Sleep Time in minutes, greater values mean longer time spent asleep.

Objective sleep measures based on EEG: Wake After Sleep OnsetAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Wake After Sleep Onset (WASO) from EEG. Wake After Sleep Onset in minutes, greater values mean longer time spent awake.

Objective sleep measures based on EEG: Slow Wave ActivityAt baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Slow Wave Activity (SWA) power density from EEG.

Cognitive performances from the CANTAB: Pattern Recognition Memory (PRM)At baseline, at 10-12 weeks and at 24 weeks after the start of the intervention

Change in Pattern Recognition Memory \[PRM - Percent correct immediate/delayed (range: 0-100; bad to good)\].

Treatment-mediated association between changes in sleep and cognitionAt 10-12 weeks and at 24 weeks after the start of the intervention

Mediation estimate of the extent to which exposure to eCBTi+ explains the association between improved sleep and improved cognition

Satisfaction from System Usability ScaleAt 10-12 weeks after the start of the intervention

Score on the System Usability Scale, reflecting the degree to which participants were satisfied with the eCBTi+ and the control intervention. Percentage ranging between 0 and 100%.

Memory encoding fMRI activationsAt baseline, at 24 weeks after the start of the intervention

Change in fMRI activation level (arbitrary units) in the hippocampus, temporal lobe and prefrontal cortex during the memory encoding task.

Cognitive performance (classical neuropsychological tests)At baseline, at 24 weeks after the start of the intervention

all subscales from classical neuropsychological test battery (Trail Making Test A \[TMT-A\], Digit Symbol Substitution test (WAIS), Boston Naming Test, Digit Span - forward and backward (WAIS), Rey Auditory Verbal Learning test, Logical Memory I and II (Wechsler Memory Scale), Brief Visuospatial Memory Test Revised (BVMT-R), Trail Making Test B \[TMT-B\], Verbal Fluency Test (from D-KEFS), Color-Word Interference Test \[Stroop test, from D-KEFS\]).

Cortical thickness measuresAt baseline, at 24 weeks after the start of the intervention

Change in cortical thickness (mm) in the prefrontal cortex and precuneus.

Technology acceptanceAt 10-12 weeks after the start of the intervention

Score on the extended version of the Technology Acceptance Model-2 reflecting th degree to which participants use and intend to use the eCBTi+ (and control intervention) as implemented on e-SPACE. Each process influencing technology acceptance is scored on a 7-point Likert scale.

Trial Locations

Locations (2)

The Royal's Institute of Mental Health Research (IMHR)

🇨🇦

Ottawa, Ontario, Canada

Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de l'Île-de-Montréal. CCSMTL - IUGM

🇨🇦

Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath